Financial News
Pfizer enlists children and adults for Lyme disease vaccine in a late stage clinical trial
August 09, 2022 at 11:01 AM EDT
On Monday, Pfizer and Valneva announced they will enlist 6,000 participants for a late-stage clinical trial of a Lyme disease vaccine.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
